Article Dans Une Revue Journal of Visceral Surgery Année : 2019

Management of colorectal peritoneal metastases: Expert opinion

Résumé

When peritoneal metastases are diagnosed (strong agreement of experts): (i) seek advice from a multidisciplinary coordination meeting (MCM) with large experience in peritoneal disease (e.g. BIG RENAPE network); (ii) transfer (or not) the patient to a referral center with experience in hyperthermic intraperitoneal chemotherapy (HIPEC), according to the advice of the MCM. With regard to systemic chemotherapy (strong agreement of experts): (i) it should be performed both before and after surgery, (ii) for no longer than 6 months; (iii) without postoperative anti-angiogenetic drugs. With regard to cytoreductive surgery (strong agreement of experts): (i) Radical surgery requires a xiphopubic midline incision; (ii) no cytoreductive surgery via laparoscopy. With regard to HIPEC: HIPEC can be proposed for trials outside an HIPEC referral center (weak agreement between experts): (i) if surgery is radical; (ii) if the expected morbidity is "reasonable"; (iii) if the indication for HIPEC was suggested by a MCM, and; (iv) mitomycin is preferred to oxaliplatin (which cannot be recommended) for this indication.

Fichier principal
Vignette du fichier
S1878788619301274.pdf (116.36 Ko) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)
Licence

Dates et versions

hal-03489199 , version 1 (20-07-2022)

Licence

Identifiants

Citer

K. Abboud, T. André, M. Brunel, M. Ducreux, C. Eveno, et al.. Management of colorectal peritoneal metastases: Expert opinion. Journal of Visceral Surgery, 2019, 156, pp.377 - 379. ⟨10.1016/j.jviscsurg.2019.08.002⟩. ⟨hal-03489199⟩
137 Consultations
183 Téléchargements

Altmetric

Partager

  • More